# Dosing in Special Populations

> Dosing in special populations for NEET-PG Pharmacology: paediatric and neonatal pharmacokinetics, geriatric prescribing, renal and hepatic dose adjustment, TDM.

- Canonical URL: https://prepelephant.com/topics/neet-pg/pharmacology/special-population-dosing
- Exam / course: NEET-PG · Subject: Pharmacology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-02
- Last updated: 2026-10-02
- How to cite: "Dosing in Special Populations", PrepElephant, https://prepelephant.com/topics/neet-pg/pharmacology/special-population-dosing

## Direct answer

Drug dosing must be individualised at the extremes of age and in organ failure. Neonates have immature hepatic glucuronidation and low glomerular filtration — chloramphenicol's grey baby syndrome and sulphonamide-induced kernicterus are the classic consequences — while children metabolise many drugs faster per kilogram and need weight-based dosing. In the elderly, reduced renal function, altered body composition and increased receptor sensitivity demand the start-low-go-slow approach, with creatinine clearance estimated by the Cockcroft-Gault equation because serum creatinine alone misleads in sarcopenic patients. Renal impairment extends intervals or reduces doses of renally cleared drugs, hepatic impairment demands caution with high-extraction drugs, and therapeutic drug monitoring guides narrow-index agents.

## What you must remember

- **Neonatal pharmacokinetics:** immature glucuronidation caused the grey baby syndrome with chloramphenicol; reduced albumin and displaced bilirubin explain sulphonamide kernicterus; low glomerular filtration at birth necessitates extended dosing intervals for aminoglycosides.
- **Paediatric dosing:** mg per kg calculations dominate; young children often clear drugs faster than adults per kilogram (higher mg per kg doses), and G6PD deficiency and growth considerations shape drug choice.
- **Geriatric prescribing:** reduced renal clearance and increased sensitivity to benzodiazepines, opioids, anticoagulants and anticholinergics; anticholinergic burden and orthostatic hypotension drive falls; deprescribing reviews and criteria such as the Beers list flag hazardous drugs.
- **Renal dosing rule:** loading doses usually stay unchanged, maintenance doses are reduced or intervals extended for renally eliminated drugs — metformin (avoid eGFR below 30), DOACs, aminoglycosides, vancomycin, digoxin, gabapentin and morphine (active metabolites accumulate).
- **Hepatic dosing:** high first-pass extraction drugs (propranolol, morphine, lignocaine) reach several-fold higher levels in cirrhosis; lorazepam and oxazepam, cleared by glucuronidation, are preferred; Child-Pugh class informs anticancer decisions.
- **Cockcroft-Gault creatinine clearance:** estimated from age, weight and serum creatinine — muscle mass loss in the elderly produces deceptively normal creatinine despite poor clearance.
- **Therapeutic drug monitoring drugs:** digoxin, phenytoin, lithium, aminoglycosides, vancomycin, theophylline, methotrexate, ciclosporin and tacrolimus — narrow therapeutic index plus serious toxicity, with levels guiding dose.

## Common confusion

Serum creatinine is persistently mistaken for renal function: a "normal" creatinine of 1.0 in a frail 80-kilogram 85-year-old may reflect a creatinine clearance near 40 mL per minute, needing dose reduction. The second confusion is loading versus maintenance dosing — unreduced maintenance causes accumulation toxicity in organ impairment.

## Exam-focused takeaway

Stems include the neonate with grey collapses on chloramphenicol (glucuronidation deficiency), the elderly patient on diazepam falling at night (start-low-go-slow and benzodiazepine caution), the metformin patient with eGFR 25 (stop), the cirrhotic needing sedation (lorazepam), and the list of TDM drugs. Calculations may ask which Cockcroft-Gault inputs matter or which drugs need interval extension in renal failure. Anchoring one signature example per population answers nearly every question.

## Frequently asked questions

### Why did chloramphenicol cause grey baby syndrome?

Neonates lack mature hepatic glucuronidation, so unconjugated chloramphenicol accumulates, producing grey cyanosis, circulatory collapse and death.

### How does ageing change drug handling?

Reduced renal clearance, altered body composition and heightened target-organ sensitivity mean lower starting doses, longer intervals and regular deprescribing review.

### Which drugs need dose reduction in renal impairment?

Renally cleared agents — aminoglycosides, vancomycin, digoxin, DOACs, metformin, gabapentin and morphine (via accumulated metabolites) — reduced or interval-extended.

### Why estimate creatinine clearance rather than trust serum creatinine?

In sarcopenic elderly patients serum creatinine stays deceptively low despite poor filtration; Cockcroft-Gault combines age, weight and creatinine to reveal true clearance.

### Which drugs are monitored by therapeutic drug monitoring?

Digoxin, phenytoin, lithium, aminoglycosides, vancomycin, theophylline, methotrexate and the calcineurin inhibitors, all with narrow therapeutic indices.